Gutfreund Shay, Leon Pia, Graffi Shmuel, Busin Massimo
Department of Ophthalmology, Villa Igea Hospital, and IRFO, Istituto internazionale per la Ricerca e Formazione in Oftalmologia, Forlì, Italy.
Department of Ophthalmology, Villa Igea Hospital, and IRFO, Istituto internazionale per la Ricerca e Formazione in Oftalmologia, Forlì, Italy.
Am J Ophthalmol. 2017 Mar;175:129-136. doi: 10.1016/j.ajo.2016.12.012. Epub 2016 Dec 23.
To report the indications and long-term outcomes of deep anterior lamellar keratoplasty (DALK) performed after Descemet stripping automated endothelial keratoplasty (DSAEK) in cases of visually significant stromal opacities.
Retrospective, interventional, consecutive case series.
Setting: Private hospital.
Thirteen eyes that underwent DALK after DSAEK at our institution. Indications for DALK after DSAEK included both stromal opacities persisting after DSAEK and stromal opacities occurring secondarily in post-DSAEK corneas. DALK was always performed in a standardized fashion including exchange of a disc of full-thickness recipient cornea (up to the DSAEK stromal surface),7.0 mm in diameter, with a donor lamella obtained by microkeratome-assisted dissection, punched to 7.0 mm and sutured into place with a double running 10-0 nylon suture.
Best spectacle-corrected visual acuity (BSCVA), manifest refraction, and endothelial cell density (ECD).
Mean follow-up was 26 ± 18 months (range = 6-60 months). Indications for DSAEK were full-thickness graft failure (n = 8), DSAEK graft failure (n = 3), and pseudophakic bullous keratopathy (n = 2). Indications for subsequent DALK were persisting stromal opacity (n = 9) and stromal opacities newly occurred after DSAEK as a result of HSV keratitis (n = 2) or interface infection (n = 2). After complete suture removal, mean BSCVA was 20/28 (0.14 ± 0.8 logMAR) in eyes without ocular comorbidities affecting visual acuity (n = 7), while refractive astigmatism was within 4 diopter (D) in all but 1 eye (average = 3.2 ± 1.4 D). No intraoperative complications were recorded.
Performing DALK on DSAEK eliminates the need for open-sky surgery, achieving visual results comparable to those of penetrating keratoplasty, while sparing a healthy endothelial graft.
报告在具有明显视觉意义的基质混浊病例中,在Descemet膜剥除自动内皮角膜移植术(DSAEK)后进行深前板层角膜移植术(DALK)的适应证及长期效果。
回顾性、干预性、连续病例系列研究。
地点:私立医院。
在我们机构接受DSAEK术后行DALK的13只眼。DSAEK术后行DALK的适应证包括DSAEK术后持续存在的基质混浊以及DSAEK术后角膜继发出现的基质混浊。DALK均采用标准化方式进行,包括用直径7.0mm的全层受体角膜片(直至DSAEK的基质表面)替换,通过微型角膜刀辅助剖切获取供体板层,冲压至7.0mm并用10-0尼龙线双连续缝合固定到位。
最佳矫正视力(BSCVA)、显验光及内皮细胞密度(ECD)。
平均随访时间为26±18个月(范围=6 - 60个月)。DSAEK的适应证为全层植片失败(n = 8)、DSAEK植片失败(n = 3)和人工晶状体眼大泡性角膜病变(n = 2)。后续DALK的适应证为持续的基质混浊(n = 9)以及DSAEK术后因单纯疱疹病毒性角膜炎(n = 2)或界面感染(n = 2)新出现的基质混浊。在完全拆除缝线后,不伴有影响视力的眼部合并症的眼(n = 7)的平均BSCVA为20/28(0.14±0.8 logMAR),除1只眼外所有眼的屈光性散光均在4屈光度(D)以内(平均=3.2±1.4 D)。未记录到术中并发症。
在DSAEK术后行DALK无需进行开放式手术,可获得与穿透性角膜移植术相当的视觉效果,同时保留健康的内皮植片。